4//SEC Filing
Jureller John M 4
Accession 0001140361-21-002175
CIK 0001498068other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:38 PM ET
Size
5.2 KB
Accession
0001140361-21-002175
Insider Transaction Report
Form 4
Jureller John M
Director
Transactions
- Disposition to Issuer
Common Stock
2021-01-25−49,435→ 0 total
Footnotes (1)
- [F1]On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration.
Documents
Issuer
American Renal Associates Holdings, Inc.
CIK 0001498068
Entity typeother
Related Parties
1- filerCIK 0001566300
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:38 PM ET
- Size
- 5.2 KB